Estimating the cost burdens of illness in society is essential to governmental and private health policy decisions; cost-benefit and cost-effectiveness analyses, technology assessment, and agency budgets rely on such estimates. Direct cost, loss in output cost, and psychosocial cost have no standard measurements or methods of estimation. Alternative approaches are reviewed and improvements suggested.